2018年6月13日 · Objectives: In Japan, sodium-glucose co-transporter type 2 (SGLT2) inhibitors have been reported to be associated with serious skin and subcutaneous tissue disorders. A …

Sodium-glucose co-transporter 2 inhibitors (SGLT2-I) have revolutionized the treatment of type 2 diabetes mellitus during the last decade. It has not only proven to be very effective for …

Skin toxicity emerged as potential signal (e.g., rash, photosensitivity, urticaria as PTs), both for SGLT2-Is as a class and as individual drugs. Severe adverse skin events (81 reports, 7% of …

2021年11月7日 · Toxidermia, otherwise known as cutaneous adverse drug reactions (CADRs), are skin manifestations of drug administration. While most are mild, there can be a broad …

2024年12月31日 · According to post-marketing surveillance of SGLT2 inhibitors, infections, pruritus, photosensitivity, and urticaria topped the reported list of 1136 cases of skin and …

Hypersensitivity adverse events (AEs) have been reported in some patients with sodium-glucose cotransporter 2 (SGLT2) inhibitors, including a recent report of dermatological AEs in Japan.

2024年4月22日 · Comparing incidence rates of various inflammatory skin diseases among patients starting their type 2 diabetes treatment either on sodium-glucose cotransporter-2 …

2024年12月22日 · Skin disorders occur more frequently with sodium-dependent glucose cotransporter type 2 (SGLT2) inhibitors than with other antidiabetic drugs. We conducted basic …

2018年6月13日 · Objectives: In Japan, sodium-glucose co-transporter type 2 (SGLT2) inhibitors have been reported to be associated with serious skin and subcutaneous tissue disorders. A …

2022年8月2日 · The most common symptoms are itching, redness and tears in the genital skin, making it uncomfortable to sit down, pass urine or have sexual intercourse. Urinary tract …